학술논문
A nationwide assessment of hepatocellular adenoma resection: Indications and pathological discordance
Document Type
article
Author
Martijn P. D. Haring; Arthur K. E. Elfrink; Christiaan A. J. Oudmaijer; Paul C. M. Andel; Alicia Furumaya; Nenke de Jong; Colin J. J. M. Willems; Thijs Huits; Julie M. L. Sijmons; Eric J. T. Belt; Koop Bosscha; Esther C. J. Consten; Mariëlle M. E. Coolsen; Peter van Duijvendijk; Joris I. Erdmann; Paul Gobardhan; Robbert J. de Haas; Tjarda van Heek; Hwai‐Ding Lam; Wouter K. G. Leclercq; Mike S. L. Liem; Hendrik A. Marsman; Gijs A. Patijn; Türkan Terkivatan; Babs M. Zonderhuis; Izaak Quintus Molenaar; Wouter W. te Riele; Jeroen Hagendoorn; Alexander F. M. Schaapherder; Jan N. M. IJzermans; Carlijn I. Buis; Joost M. Klaase; Koert P. de Jong; Vincent E. de Meijer
Source
Hepatology Communications, Vol 7, Iss 1, Pp e2110-e2110 (2023)
Subject
Language
English
ISSN
2471-254X
Abstract
Hepatocellular adenomas (HCAs) are benign liver tumors associated with bleeding or malignant transformation. Data on the indication for surgery are scarce. We analyzed indications and outcome of patients operated for HCAs 50 mm (52%), suspicion of (pre)malignancy (28%), and (previous) bleeding (5.1%). No difference was observed in HCA‐subtype distribution between small and large tumors. Ninety‐six (43%) patients had a postoperative change in diagnosis. Independent risk factors for change in diagnosis were tumor size